Literature DB >> 20011437

Extracolonic manifestations of hereditary colorectal cancer syndromes.

Daniel A Anaya1, George J Chang, Miguel A Rodriguez-Bigas.   

Abstract

Familial colorectal adenocarcinoma (CRC) accounts for approximately 15 to 20% of CRC. Of these, hereditary nonpolyposis colorectal cancer (HNPCC) and familial adenomatous polyposis (FAP) represent the most common hereditary syndromes associated with CRC, followed by other less common diseases including juvenile polyposis (JP) and Peutz-Jeghers syndrome (PJS). Extracolonic manifestations are common in each of these syndromes having significant implications for surveillance and management in at-risk individuals. The authors review the most common and clinically relevant extracolonic manifestations for each of these syndromes focusing on incidence, presentation, genotype/phenotype correlations, and management (including surveillance) strategies.

Entities:  

Keywords:  Hereditary polyposis; colorectal cancer; extracolonic manifestations

Year:  2008        PMID: 20011437      PMCID: PMC2780251          DOI: 10.1055/s-0028-1089941

Source DB:  PubMed          Journal:  Clin Colon Rectal Surg        ISSN: 1530-9681


  86 in total

1.  Colorectal and extracolonic cancer variations in MLH1/MSH2 hereditary nonpolyposis colorectal cancer kindreds and the general population.

Authors:  K M Lin; M Shashidharan; C A Ternent; A G Thorson; G J Blatchford; M A Christensen; S J Lanspa; S J Lemon; P Watson; H T Lynch
Journal:  Dis Colon Rectum       Date:  1998-04       Impact factor: 4.585

2.  Familial adenomatous polyposis.

Authors:  E I Traboulsi
Journal:  Dis Colon Rectum       Date:  1989-07       Impact factor: 4.585

Review 3.  Desmoid tumors.

Authors:  T Anthony; M A Rodriguez-Bigas; T K Weber; N J Petrelli
Journal:  J Am Coll Surg       Date:  1996-04       Impact factor: 6.113

4.  Very high risk of cancer in familial Peutz-Jeghers syndrome.

Authors:  F M Giardiello; J D Brensinger; A C Tersmette; S N Goodman; G M Petersen; S V Booker; M Cruz-Correa; J A Offerhaus
Journal:  Gastroenterology       Date:  2000-12       Impact factor: 22.682

5.  MR appearances of desmoid tumors in familial adenomatous polyposis.

Authors:  J C Healy; R H Reznek; S K Clark; R K Phillips; P Armstrong
Journal:  AJR Am J Roentgenol       Date:  1997-08       Impact factor: 3.959

6.  Cancer risk associated with germline DNA mismatch repair gene mutations.

Authors:  M G Dunlop; S M Farrington; A D Carothers; A H Wyllie; L Sharp; J Burn; B Liu; K W Kinzler; B Vogelstein
Journal:  Hum Mol Genet       Date:  1997-01       Impact factor: 6.150

7.  Peutz-Jeghers syndrome: its natural course and management.

Authors:  J Utsunomiya; H Gocho; T Miyanaga; E Hamaguchi; A Kashimure
Journal:  Johns Hopkins Med J       Date:  1975-02

8.  The risk of endometrial cancer in hereditary nonpolyposis colorectal cancer.

Authors:  P Watson; H F Vasen; J P Mecklin; H Järvinen; H T Lynch
Journal:  Am J Med       Date:  1994-06       Impact factor: 4.965

9.  Guidance on gastrointestinal surveillance for hereditary non-polyposis colorectal cancer, familial adenomatous polypolis, juvenile polyposis, and Peutz-Jeghers syndrome.

Authors:  M G Dunlop
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

10.  Slow progression of periampullary neoplasia in familial adenomatous polyposis.

Authors:  Kouros L Moozar; Lisa Madlensky; Terri Berk; Steven Gallinger
Journal:  J Gastrointest Surg       Date:  2002 Nov-Dec       Impact factor: 3.267

View more
  11 in total

Review 1.  Hereditary Polyposis Syndromes.

Authors:  Trilokesh D Kidambi; Divyanshoo R Kohli; N Jewel Samadder; Aparajita Singh
Journal:  Curr Treat Options Gastroenterol       Date:  2019-12

2.  Familial Adenomatous Polyposis (FAP)-A Case Study and Review of Literature.

Authors:  Santosh Bhimrao Dalavi; Tanwar Harshwardhan Vedpalsingh; Sanket Subhash Bankar; Mohd Hamid Shafique Ahmed; Dattatray Nivrutti Bhosale
Journal:  J Clin Diagn Res       Date:  2015-03-01

Review 3.  How many is too many? Polyposis syndromes and what to do next.

Authors:  Nina Gupta; Christine Drogan; Sonia S Kupfer
Journal:  Curr Opin Gastroenterol       Date:  2022-01-01       Impact factor: 3.287

4.  Desmoid tumors: clinical features and outcome of an unpredictable and challenging manifestation of familial adenomatous polyposis.

Authors:  Fábio Guilherme Campos; Carlos Augusto Real Martinez; Marleny Novaes; Sérgio Carlos Nahas; Ivan Cecconello
Journal:  Fam Cancer       Date:  2015-06       Impact factor: 2.375

5.  Thymic cancer in lynch syndrome: an unusual association.

Authors:  Deepali Pandey; David Scott Shepro
Journal:  BMJ Case Rep       Date:  2020-04-08

Review 6.  Chemoprevention of colorectal cancer.

Authors:  Michaela Lang; Christoph Gasche
Journal:  Dig Dis       Date:  2014-12-17       Impact factor: 2.404

7.  Pulmonary sclerosing hemangioma in a 21-year-old male with metastatic hereditary non-polyposis colorectal cancer: report of a case.

Authors:  Tobias S Schiergens; Philipe N Khalil; Doris Mayr; Wolfgang E Thasler; Martin K Angele; Rudolf A Hatz; Karl-Walter Jauch; Axel Kleespies
Journal:  World J Surg Oncol       Date:  2011-06-06       Impact factor: 2.754

8.  Familial adenomatous polyposis in three generations of a single family: a case study.

Authors:  Jure Murgic; Iva Kirac; Zeljko Soldic; Davor Tomas; Mario Zovak; Ante Bolanca; Andrzej Plawski; Y Banasiewicz; Zvonko Kusic
Journal:  Case Rep Oncol       Date:  2014-05-28

9.  APC mosaicism in a young woman with desmoid type fibromatosis and familial adenomatous polyposis.

Authors:  Astrid Tenden Stormorken; Thomas Berg; Ole-Jacob Norum; Toto Hølmebakk; Kristin Aaberg; Sonja E Steigen; Eli Marie Grindedal
Journal:  Fam Cancer       Date:  2018-10       Impact factor: 2.375

Review 10.  Colorectal Cancer and Probiotics: Are Bugs Really Drugs?

Authors:  Purushottam Lamichhane; Morgan Maiolini; Omar Alnafoosi; Sedra Hussein; Hasan Alnafoosi; Stewart Umbela; Tayanna Richardson; Nevien Alla; Narottam Lamichhane; Bobban Subhadra; Rahul R Deshmukh
Journal:  Cancers (Basel)       Date:  2020-05-05       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.